Diabetes Obes Metab 18(4):317332 [DOI] [PMC free article] [PubMed] [Google Scholar] Madsen LW, Knauf JA, Gotfredsen C, Pilling A, Sjgren I, Andersen S et al (2012) GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation
McIntyre N, Holdsworth CD, Turner DS
Semaglutide Compound Restrictions: FDA Ends Compound Versions of Ozempic & Wegovy: Here Are Available Options FDA Declares End to Semaglutide and Tirzepatide Shortage, Restricting Compounding Production of the GLP-1s for NJ Residents Using These Medications for Weight Loss May marks a significant transition for many people on weight loss medications across New Jersey
However, when patients reported weight loss on these drugs, companies began to consider them as a treatment for obesity
The provider overseeing your care recommends it when your labs , symptoms , and goals line up with what this peptide can do
Bring photographs if possible, as skin findings may not be present during your visit